“…Transcription factor encoding gene HNF4A [ 12 ], genes encoding renin-angiotensin system (RAS) including ACE and AGT [ 35 , 44 ]; insulin-resistance genes of VDR ( Fox1 ) [ 33 ], adiponectin [ 34 , 40 ], and PAI-1 [ 46 ]; insulin-sensitive gene IRS [ 12 , 31 ]; glucose homeostasis genes CAPN10 [ 47 ], PPARα , and POR [ 32 , 36 ]; and inflammatory factor genes such as CCL5 [ 34 , 48 ], IL-6 [ 37 ], IL-1B , IL-2 , IL-4 , IL-17 , IL-7R, and IL-17R [ 18 , 29 , 39 ] have been shown to contribute to the pathogenesis of PTDM. Lower GPX1 enzyme activity, caused by GPX1 599C to T mutation, increases the exposure of pancreatic β cells to oxidative stress and development of PTDM [ 24 , 49 ]. Additionally, ATF6 , GST ( SOD and CAT ), INFγ and ( TGFβ1 , TNFα , and STAT4 ) polymorphisms, which play important roles in endoplasmic reticulum stress, oxidative stress, and inflammation respectively, were not found to be associated with PTDM [ 16 , 28 , 41 , 42 , 45 , 49 ].…”